<SEC-DOCUMENT>0001913491-25-000001.txt : 20250611
<SEC-HEADER>0001913491-25-000001.hdr.sgml : 20250611
<ACCEPTANCE-DATETIME>20250611080238
ACCESSION NUMBER:		0001913491-25-000001
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250611
DATE AS OF CHANGE:		20250611

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Connect Biopharma Holdings Ltd
		CENTRAL INDEX KEY:			0001835268
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40212
		FILM NUMBER:		251038814

	BUSINESS ADDRESS:	
		STREET 1:		3580 CARMEL MOUNTAIN ROAD, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-727-1040

	MAIL ADDRESS:	
		STREET 1:		3580 CARMEL MOUNTAIN ROAD, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wei Zheng
		CENTRAL INDEX KEY:			0001913491
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O CONNECT BIOPHARMA HOLDINGS LTD
		STREET 2:		SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL
		CITY:			6 BEIJING WEST ROAD, TAICANG
		STATE:			F4
		ZIP:			215400
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001913491</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001835268</issuerCik>
      <issuerName>Connect Biopharma Holdings Ltd</issuerName>
      <secFileNumber>001-40212</secFileNumber>
      <issuerAddress>
        <com:street1>3580 CARMEL MOUNTAIN ROAD, SUITE 200</com:street1>
        <com:city>SAN DIEGO</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>92130</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>858-727-1040</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Wei Zheng</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Individual Filer</name>
        <address>
          <com:street1>PO Box 415</com:street1>
          <com:street2>122 15th Street</com:street2>
          <com:city>Del Mar</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92014</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>39775</noOfUnitsSold>
      <aggregateMarketValue>32217.75</aggregateMarketValue>
      <noOfUnitsOutstanding>55561056</noOfUnitsOutstanding>
      <approxSaleDate>06/11/2025</approxSaleDate>
      <securitiesExchangeName>N/A</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <acquiredDate>03/19/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Compensation-Stock Award</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>39775</amountOfSecuritiesAcquired>
      <paymentDate>03/19/2021</paymentDate>
      <natureOfPayment>No payment - Stock awarded as compensation for services</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>This is a private transaction in which the seller listed in Section 2(a) above is selling the ordinary shares described above directly to the issuer's current Chief Executive Officer, Barry D. Quart, Pharm.D., at market price.</remarks>
    <noticeSignature>
      <noticeDate>06/11/2025</noticeDate>
      <signature>zheng Wei</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
